Výsledky vyhledávání - "R Myllykangas-Luosujärvi"

Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis

Autor: G.-Y. Genti, C. Amante, B. Sarembock, C. T. Chow, C. A. F. Zerbini, S. L. Chen, F. Vrijens, M. Laurenzi, R. Myllykangas-Luosujärvi, D. B. Rodgers, G. Pasero, H. S. Lu, L. De Tora, D.S.K. Choon, A. Moan

Publikováno v: Scandinavian Journal of Rheumatology. 31:337-344

Objective : To compare the efficacy and safety of rofecoxib 12.5 mg once daily to naproxen 500 mg twice daily in patients S 40 years of age with knee or hip osteoarthritis (OA). Methods : Two identical 6-week, randomized, double-blind studies were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fa967180ed2673e6b9b40020159c246
https://doi.org/10.1080/030097402320817059

Zobrazit plný text záznamu

Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration

Autor: R, Myllykangas-Luosujärvi, H S, Lu, S L, Chen, D, Choon, C, Amante, C T, Chow, G, Pasero, Gy, Genti, B, Sarembock, C A F, Zerbini, F, Vrijens, A, Moan, D B, Rodgers, L, De Tora, M, Laurenzi

Publikováno v: Scandinavian journal of rheumatology. 31(6)

To compare the efficacy and safety of rofecoxib 12.5 mg once daily to naproxen 500 mg twice daily in patientsor = 40 years of age with knee or hip osteoarthritis (OA).Two identical 6-week, randomized, double-blind studies were conducted (1 in Africa,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::56683d95b6e7c0e945c8207b165d1aec
https://pubmed.ncbi.nlm.nih.gov/12492248

Zobrazit plný text záznamu

Current features of peptic ulcer disease in Finland: incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years

Autor: H. Paimela, Eero Kivilaakso, L. Paimela, R. Myllykangas-Luosujärvi

Publikováno v: Scandinavian journal of gastroenterology. 37(4)

Medical therapy of peptic ulcer disease (PUD) has improved dramatically during the past 20 years with the introduction of modern antisecretory drugs as well as eradication therapy of Helicobacter pylori. During the 1990s, there has been a 3-fold incr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ced92d550dddd5a60fd89de2fac1efe
https://pubmed.ncbi.nlm.nih.gov/11989829

Zobrazit plný text záznamu

Mortality associated with cervical spine disorders: a population-based study of 1666 patients with rheumatoid arthritis who died in Finland in 1989

Autor: Markku J Kauppi, Hannu Kautiainen, R. Myllykangas‐Luosujärvi, Marko H Neva

Publikováno v: Rheumatology (Oxford, England). 40(2)

Objective. To evaluate the mortality associated with cervical spine deformities in rheumatoid arthritis (RA) based on national data. Methods, The role of rheumatoid disorders of the cervical spine as a cause of death was studied in 1666 subjects who

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca2b424e2f592be6f05cd0ed7b8bdfa
https://pubmed.ncbi.nlm.nih.gov/11257146

Zobrazit plný text záznamu

Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives

Autor: R Myllykangas-Luosujärvi, E Jantunen

Publikováno v: Bone marrow transplantation. 25(4)

Autoimmune diseases include a heterogenous group of disorders with variable presentation and severity. Immunosuppressive and immunomodulatory therapies are often used for treatment with considerable success in some cases. These diseases may also be s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d32d1bdae9d065d0dd195930a343a325
https://pubmed.ncbi.nlm.nih.gov/10723576

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání